Resveratrol improves insulin resistance, glucose and lipid metabolism in patients with non-alcoholic fatty liver disease: A randomized controlled trial-Reference-Cited by-同舟云学术

Resveratrol improves insulin resistance, glucose and lipid metabolism in patients with non-alcoholic fatty liver disease: A randomized controlled trial

Published:2015-03 Issue:3 Volume:47 Page:226-232
ISSN:1590-8658
Container-title:Digestive and Liver Disease
language:en
Short-container-title:Digestive and Liver Disease

Author:

Chen Shihui,Zhao Xiaolan,Ran Li,Wan Jing,Wang Xiaofang,Qin Yu,Shu Furong,Gao Yanxiang,Yuan Lijia,Zhang Qianyong,Mi Mantian

Publisher

Elsevier BV

Subject

Gastroenterology,Hepatology

Reference41 articles.

1. Non-alcoholic fatty liver disease: a spectrum of clinical and pathological severity;Matteoni;Gastroenterology,1999

2. Cardiovascular and systemic risk in non-alcoholic fatty liver disease – atherosclerosis as a major player in the natural course of NAFLD;Lonardo;Current Pharmaceutical Design,2013

3. A meta-analysis of randomized trials for the treatment of non-alcoholic fatty liver disease;Musso;Hepatology,2010

4. From NAFLD in clinical practice to answers from guidelines;Nascimbeni;Journal of Hepatology,2013

5. Risk of cardiovascular, cardiac and arrhythmic complications in patients with non-alcoholic fatty liver disease;Ballestri;World Journal of Gastroenterology: WJG,2014

Cited by 274 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. Insights into the Therapeutic and Pharmacological Properties of Resveratrol as a Nutraceutical Antioxidant Polyphenol in Health Promotion and Disease Prevention;Current Reviews in Clinical and Experimental Pharmacology;2024-11

2. Hepatocellular Interactions of Potential Nutraceuticals in the Management of Inflammatory NAFLD;Cell Biochemistry and Function;2024-09-05

3. Dietary Polyphenols and Gut Microbiota Cross-Talk: Molecular and Therapeutic Perspectives for Cardiometabolic Disease: A Narrative Review;International Journal of Molecular Sciences;2024-08-22

4. Current strategies for nonalcoholic fatty liver disease treatment (Review);International Journal of Molecular Medicine;2024-08-08

5. S2k-Leitlinie Klinische Ernährung in der Hepatologie;Aktuelle Ernährungsmedizin;2024-08